compname posts qtrly adjusted diluted earnings per share of $3.96.
compname posts qtrly adjusted diluted earnings per share of $3.96.
quest diagnostics inc - raises full year 2021 outlook to reflect higher than anticipated covid-19 testing volumes.
quest diagnostics inc - q3 reported diluted earnings per share (eps) of $4.02.
quest diagnostics inc - q3 reported diluted earnings per share (eps) of $4.02.
quest diagnostics inc - qtrly adjusted diluted earnings per share of $3.96.
quest diagnostics inc - qtrly adjusted diluted earnings per share of $3.96.
quest diagnostics inc - had a strong q3, as covid-19 molecular volumes increased throughout summer.
quest diagnostics inc - in late summer we experienced some softness in base business across country, but saw an overall rebound in september.
quest diagnostics inc - base business continued to improve sequentially in q3 which speaks to ongoing recovery.
quest diagnostics inc - q3 revenues of $2.77 billion, down 0.4% from 2020.
quest diagnostics inc - sees fy net revenues $10.45 billion to $10.60 billion.
quest diagnostics inc - sees fy adjusted diluted earnings per share $13.50 - $13.90.
quest diagnostics inc - sees fy reported diluted earnings per share $14.69 - $15.09.
